It has broad neutralisation potential, says vaccine immunologist Sanjeev Kumar of Delhi-based International Centre for Genetic Engineering and Biotechnology that conducted collaborative research with National Institute of Malaria Research (New Delhi) and Emory Vaccine Center (Atlanta, USA)